Search
Now showing items 1-10 of 10
Cellular Reprogramming via Epi-CRISPRs-lnduced Targeted DNA Methylation
(COST Action CA1611, 2017)
Ferroptosis as a Novel Determinant of β-Cell Death in Diabetic Conditions
(London:Hindawi, 2022)
Involvement of Ferroptosis in Diabetes-Induced Liver Pathology
(Basel: MDPI, 2022)
Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
(Lausanne: Frontiers Media SA, 2022)
Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
(Lausanne: Frontiers Media SA, 2023)
Uloga ciljanih (epi)genetičkih modifikacija u potencijalnoj terapiji dijabetesa / The role of targeted (epi)genetic modifications in potential diabetes therapy
(Belgrade: Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 2023)
Sulforaphane prevents diabetes-induced hepatic ferroptosis by activating Nrf2 signaling axis
(Hoboken: Wiley, 2024)
Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting.
(Frontiers in Endocrinology, 2023)